Celestial Biolabs Limited SHARE PRICE [LIVE]

BSE: 532871
To view real time prices Login to your account
Already an existing customer? - Login Now!
BSE Click here to view BSE data
Live Chart
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
Div yield:

Fundamental analysis


0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Not Applicable
MARKET CAP (Micro Cap Stock)Rs Cr
PE (TTM) 0.00
PE Ratio-4.29
Price to Book Value0.04
EV to EBIT12.06
EV to EBITDA1.22
EV to Capital Employed0.11
EV to Sales0.33
PEG Ratio0.00
Dividend YieldNA
ROCE (Latest)2.09%
ROE (Latest)-0.85%
NameJun 19Mar 19
Promoters (Change:0.00) 26.07%26.07%
FIIs (Change:0.00) 0%0%
Mutual Funds (Change:0.00) 0%0%
Insurance Companies (Change:0.00) 0%0%
Other DIIs (Change:0.00) 0%0%
Non Institution (Change:0.00) 73.93%73.93%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Celestial Biolabs Limited

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %


Frequently Asked Questions

Can I buy Celestial Biolabs Limited (CELESTIAL) shares?

Yes, You can buy Celestial Biolabs Limited (CELESTIAL) shares by opening a Demat account with Angel One.

How do I buy Celestial Biolabs Limited (CELESTIAL) from Angel One?

Celestial Biolabs Limited (CELESTIAL) share can be brought through the following modes:
  1. Direct investment: You can buy Celestial Biolabs Limited (CELESTIAL) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Celestial Biolabs Limited (CELESTIAL) shares.

In which sector do Celestial Biolabs Limited (CELESTIAL) belong?

Celestial Biolabs Limited (CELESTIAL) belongs to Pharma.


Today's live share price for Celestial Biolabs Limited is NSE: N/A, BSE: N/A with a current market capitalization of .

CELESTIAL LABS LIMITED was incorporated as a Private Limited Company on November 19, 1997 as 'Celestial Technologies Private Limited'. Mr. Rajani Kanth Katragadda and Mr. Vijay Marur have promoted the company. The company was later converted into a Public Limited Company under the name 'Celestial Technologies Limited' on December 6, 1999 and has been subsequently renamed as 'CELESTIAL LABS LIMITED' effective from February 13, 2004. The present promoter of the company is Mr. Aditya Narayan Singh. The Original promoters sold their holding to the present promoter on 7.11.1998. The company has received ISO 9001-2000 certificate. The company has been providing customized enterprise solutions, bioinformatics services and also involved in development of biopharmaceuticals and industrial enzymes. The company is in contact with Centre for Cellular & Molecular Biology (CCMB) under the aegis of Council for Scientific and Industrial Research, Ministry of Science and Technology, Government of India and Indian Institute of Chemical Technology (IICT), premier chemical and Biological Institutions in Hyderabad to work on collaborative research projects to be funded by Department of Science and Technology New Delhi. The Company has offer both service and solutions like application management for legacy system, upgrade and maintenance system. Molecular informatics, data management, algorithm development, compliances and data curation, warehousing and visualization and custom built application are the current part of services. To strengthen the Drug molecule development and related services like Target identification and advance fragment based lead optimization solution, Celestial has developed a de novo drug design tool 'CELSUITE' to aid the pharma industry in finding the lead molecules for drug discovery and protected the IPR by filing under the Copyright Act, 1957. (Appraised and funded by Department of Science and Technology, New Delhi). The company is setting up an Industrial biotechnology facility to manufacture industrial enzymes. This facility would also include the Development laboratories for carrying out further R & D activities to develop new related products for reducing Wrinkles / Stretch marks and acceleration of wound healing from the same chemical structure of vitiligo. The proposed Facility is being set up at Shapoorji Pallonji Biotech Park in Genome Valley at Hyderabad in Andhra Pradesh.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers